Moderna cancer vaccine poised to transform the Melanoma landscape. Not long after reporting significant losses for 2023 (-$4.7Billion) and Q1 2024 (-1.2Billion) due to the fall in demand for its Covid-19 Spikevax vaccine, Moderna were presenting some altogether different news at ASCO2024. At the American Society of Clinical Oncology (ASCO) conference Moderna and Merck released more positive Phase II three-year data on their experimental cancer vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. Among new data, nearly 75% of patients who took the combination were alive without any signs or symptoms of their cancer returning at the 2½-year mark. That compares with 55.6% of patients who got Keytruda alone. The overall survival rate of patients who took the vaccine in combination with Keytruda was 96% after 2½ years. That compares with 90.2% among those who took Keytruda alone. As the companies previously announced, patients with severe forms of the cancer, known as melanoma, who received the combination were 49% less likely to die or have their cancer return than those who took Keytruda alone after roughly three years. The combination also slashed the risk of melanoma spreading to other parts of the body, or death, by 62%. https://lnkd.in/erRJUASw
Discover International
Staffing and Recruiting
London, England 116,803 followers
Talent Solutions for Life Sciences
About us
Discover International - Visionary Life Science Talent Solutions Our expert teams find exceptional people faster Our innovative Talent and Consulting solutions mean we deliver faster at every stage and every challenge of the hiring process; our product offering brings together an extensive global and local network, specialist skills, strategic guidance, and dedicated experts working together as a team. We nurture long-term partnerships with our candidates, our clients and our stakeholders, who continually recommend us to their colleagues and peers. When our contacts move to a new company, they consistently approach us to support them in finding talent in their new organisation. This organic client acquisition is testament to all that we stand for at Discover, and we are proud that more than 90% of our clients are repeat customers. We help game-changing organizations grow, making a meaningful difference at every stage of the Life Science process, through finding brilliant people faster in: Clinical Development, Clinical Operations, Biometrics, Medical Affairs, Regulatory Affairs, CMC, Quality & Compliance, Medical Writing & Communications, HEOR, Market Access, Commercial, Pharmacovigilance & Drug Safety, Technical Operations, Manufacturing, Preclinical.
- Website
-
http://www.discoverinternational.com
External link for Discover International
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Life Sciences, Pharmaceutical, Medical Devices, Clinical, Discovery, Medical, Clinical Research, Clinical Development, Medical Affairs, Drug Safety, Pharmacovigilance, biotechnology, Recruitment, Headhunting, Regulatory Affairs, staffing, contract recruitment, Biotech, and Medical Wrting
Locations
-
Primary
10 Lower Thames Street
London, England, GB
Employees at Discover International
Updates
-
Discover International reposted this
A British toddler has had her hearing restored after becoming the first person in the world to take part in a pioneering gene therapy trial with Regeneron, in a development that doctors say marks a new era in treating deafness. An incredible breakthrough from Regeneron and the original Decibel Therapeutics team, whom Regeneron acquired in August 2023. Opal Sandy was born unable to hear anything due to auditory neuropathy, a condition that disrupts nerve impulses travelling from the inner ear to the brain and can be caused by a faulty gene. After receiving an infusion containing a working copy of the gene during groundbreaking surgery that took just 16 minutes, the 18-month-old can hear almost perfectly and enjoys playing with toy drums. Watch a heart warming video from Sky News with Opal and her parents. #regeneron #decibeltherapeutics #healthimpact #genetherapy https://lnkd.in/edyQq3ns
Deaf toddler's hearing restored in world first gene therapy trial
news.sky.com
-
Goldman Sachs now predicts the global obesity market will be worth $130 Billion by 2030. The boosted projection underscores the building momentum in the GLP-1 market as more drug developers race to tap its potential, while established companies Novo Nordisk and Eli Lilly and Company aim to expand their hold. The obesity market is now set to reach $130 billion in just 6 years. That’s up from a prior forecast of $100 billion. https://lnkd.in/eizJBse6
Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030
finance.yahoo.com
-
The top 20 highest paying countries for Biotech according to Insider Monkey. To list the highest paying countries for biotechnology, Insider Monkey identified the countries with the highest demand for biotechnologists and looked at the average salaries for biotechnologists in that country. The 20 with the highest average salaries were selected and have been ranked. Insider Monkey acquired the data for average salaries of biotechnologists for each country from the Economic Research Institute (ERI). https://lnkd.in/enNxd3N7
20 Highest Paying Countries for Biotechnology
insidermonkey.com
-
A British toddler has had her hearing restored after becoming the first person in the world to take part in a pioneering gene therapy trial with Regeneron, in a development that doctors say marks a new era in treating deafness. An incredible breakthrough from Regeneron and the original Decibel Therapeutics team, whom Regeneron acquired in August 2023. Opal Sandy was born unable to hear anything due to auditory neuropathy, a condition that disrupts nerve impulses travelling from the inner ear to the brain and can be caused by a faulty gene. After receiving an infusion containing a working copy of the gene during groundbreaking surgery that took just 16 minutes, the 18-month-old can hear almost perfectly and enjoys playing with toy drums. Watch a heart warming video from Sky News with Opal and her parents. #regeneron #decibeltherapeutics #healthimpact #genetherapy https://lnkd.in/edyQq3ns
Deaf toddler's hearing restored in world first gene therapy trial
news.sky.com
-
A big thank you to Simon Adams for delivering his excellent Technical Operations training to our team in Krakow!
Fantastic day in Krakow today with the Discover International team today, training them in Pharma and BioPharm technical operations. Many thanks to the brilliant team for a day of interactive learning. #Discoverinternational
-
We wish everyone a blessed Ramadan! 🙏 #ramadankareem
-
Today, we celebrate the incredible achievements, strength, and resilience of women worldwide. Happy International Women's Day! 🌸✨ At Discover International, we honor the invaluable contributions of women in every aspect of our organization and beyond. From leadership roles to innovation, creativity, and compassion, women continue to shape and inspire our journey towards progress and equality. We stand committed to fostering an inclusive and empowering environment where every woman can thrive, succeed, and make their mark. Together, let's continue to break barriers, defy stereotypes, and uplift each other, not just today, but every day. Here's to all the remarkable women who enrich our lives and make the world a brighter place. #InternationalWomensDay #empowerwomen
-
Today, on Rare Disease Day, we shine a light on the strength and resilience of those 300 million people living with rare diseases, their families, and caregivers. #RareDiseaseDay is an opportunity to raise awareness about these often overlooked conditions and the challenges faced by those affected. This day is a reminder of the importance of advocacy, research, and support for the rare disease community. Together, we can work towards better understanding, improved treatments, and ultimately, cures for these conditions. Thank you - to all the clients and candidates I work with in this space! Donate here: https://lnkd.in/gtBWunJD